Cyclotron Noordwest B.V. reflects on a successful participation in the European Association of Nuclear Medicine (EANM) Congress 2024, held in Hamburg, Germany. A delegation from our company attended this renowned event, known as the leading platform for innovation and collaboration in nuclear medicine.

During the congress, our team gained valuable insights into the latest advancements in PET tracer technology and engaged in inspiring discussions with international experts. The event also provided excellent opportunities to explore future collaborations and advancements in diagnostic and therapeutic applications.

As a leading cyclotron facility in the Netherlands, Cyclotron Noordwest B.V. specializes in the production of F18 PET tracers for clinical use. We are open to partnerships with third parties for Contract Manufacturing Organization (CMO) projects, focusing on PET tracers with an annual application volume exceeding 250 diagnoses within the Netherlands.

If you are interested in collaboration or would like to learn more, please feel free to reach out to us. We look forward to connecting and working together to advance innovation in nuclear medicine!